| 1 |
24648585 | Interferon alfa versus interferon alfa plus cytarabine combination therapy for chronic myeloid leukemia: a meta-analysis of randomized controlled trials. | 2011 Aug |
1 |
| 2 |
16627756 | Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials. | 2006 Sep 1 |
1 |
| 3 |
16144928 | Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia. | 2005 Sep 1 |
1 |
| 4 |
12563609 | Interferon-alfa for chronic myeloid leukemia. | 2003 Jan |
2 |
| 5 |
14669283 | Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data. | 2003 Dec 15 |
1 |
| 6 |
12481403 | [Interferons and hematology]. | 2002 Nov |
1 |
| 7 |
12575210 | [The effect of interferon alone, cytosine arabinoside alone and their combined effect on hematopoietic progenitors of chronic myeloid leukemia in vitro]. | 2002 Apr |
2 |
| 8 |
11342363 | Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia. | 2001 Mar |
2 |
| 9 |
11526598 | Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition. | 2001 Jul |
2 |
| 10 |
11726320 | Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon. | 2001 Dec |
2 |
| 11 |
10942234 | Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM. | 2000 Aug |
2 |
| 12 |
11032593 | Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia. | 2000 Oct 15 |
1 |
| 13 |
10520005 | Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia. | 1999 Sep |
2 |
| 14 |
10609785 | Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. | 1999 Nov |
1 |
| 15 |
9670853 | Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells. | 1998 Jul 1 |
1 |
| 16 |
10388104 | Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases. | 1998 |
1 |
| 17 |
8742366 | Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells. | 1996 Feb |
3 |
| 18 |
8926690 | [Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped]. | 1996 Jul-Aug |
1 |
| 19 |
7672091 | Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients. | 1995 Sep |
1 |
| 20 |
8368048 | [Value of interferon-alpha in treatment of chronic myeloid leukemia]. | 1993 |
1 |
| 21 |
1592362 | Effects of recombinant human interferon-alpha, beta and gamma on the antiproliferative activity of cytarabine in K562 human myeloid leukemia clonogenic cells. | 1992 Mar-Apr |
1 |
| 22 |
7152202 | Assessment of anti-tumor cell effect of human leukocyte interferon in combination with anticancer agents by a convenient assay system in monolayer cell culture. | 1982 Aug |
2 |